1
|
Kotting P, Smith A, O'Hare MB, Giebel C, Mendis L, Shaw C, Shillito I, Rossor MN. A national open-access research registry to improve recruitment to clinical studies. Alzheimers Dement (N Y) 2021; 7:e12221. [PMID: 34938852 PMCID: PMC8659591 DOI: 10.1002/trc2.12221] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 08/27/2021] [Accepted: 09/16/2021] [Indexed: 11/09/2022]
Abstract
INTRODUCTION Barriers to recruitment for dementia studies are well documented. As part of the UK government's Dementia 2020 strategy, a nationally consistent system to increase public engagement and participation in research was launched in February 2015. METHODS We describe the development of the "Join Dementia Research" registry, including evolution of policy, involvement of people with dementia in co-production, data requirements, governance, technology, and the impact on study recruitment and what factors may have contributed to the services success. RESULTS The UK-wide online, telephone, and postal service has registered 47,071 volunteers, with 33,139 people (67.9% of all volunteers) taking part in 378 studies, with 49,954 total study enrolments. This has taken place across 295 research sites, involved 1522 researchers, and resulted in 134 peer-reviewed publications. DISCUSSION Public registries of individuals interested in research, with user-provided data enabling basic phenotyping, are effective at increasing public engagement with research and removing barriers to study recruitment. Deeper pheno/genotyping could be undertaken to improve matching, but how and when that information is collected will be a key factor.
Collapse
Affiliation(s)
- Piers Kotting
- Department of Neurodegenerative DiseasesDementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
- College of Medicine and HealthUniversity of ExeterExeterUK
| | - Adam Smith
- Department of Neurodegenerative DiseasesDementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| | - Megan B. O'Hare
- Department of Neurodegenerative DiseasesDementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| | - Clarissa Giebel
- NIHR Applied Research CollaborationNorth West CoastUniversity of LiverpoolLiverpoolUK
- Department of Primary Care & Mental HealthUniversity of LiverpoolLiverpoolUK
| | - Lakshini Mendis
- Department of Neurodegenerative DiseasesDementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| | - Clare Shaw
- NIHR Clinical Research Network Coordinating CentreUniversity of LeedsLeedsUK
| | - Imogen Shillito
- NIHR Clinical Research Network Coordinating CentreUniversity of LeedsLeedsUK
| | - Martin N. Rossor
- Department of Neurodegenerative DiseasesDementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| |
Collapse
|
2
|
Silarova B, Nelis SM, Ashworth RM, Ballard C, Bieńkiewicz M, Henderson C, Hillman A, Hindle JV, Hughes JC, Lamont RA, Litherland R, Jones IR, Jones RW, Knapp M, Kotting P, Martyr A, Matthews FE, Morris RG, Quinn C, Regan J, Rusted JM, van den Heuvel EA, Victor CR, Wu YT, Clare L. Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life. BMC Public Health 2018; 18:1214. [PMID: 30376832 PMCID: PMC6208177 DOI: 10.1186/s12889-018-6129-7] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2018] [Accepted: 10/18/2018] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND There is a major need for longitudinal research examining the experiences of people with dementia and their primary carers, as relatively little is known about how the factors associated with capability to 'live well' vary over time. The main aim of the IDEAL-2 study is to investigate how and why, over time, people with dementia and their primary carers might vary in their capability to live well with dementia, whilst exploring both their use of health and care services and their unmet needs. METHODS IDEAL-2 will build on the Improving the experience of Dementia and Enhancing Active Life (IDEAL) cohort of 1547 people (who, at recruitment between July 2014 and July 2016, had mild-to-moderate dementia), and their 1283 primary carers in Great Britain. The existing cohort will be enriched with additional participants with mild-to-moderate dementia (and their primary carers where available and willing) from the following groups: people with rarer forms of dementia, and/or those who are ≥90 years or < 65 years of age at time of recruitment. We will assess the primary outcome, capability to live well with dementia, and the factors influencing it using questionnaires at yearly intervals for 3 years. Additionally, we will seek to link the cohort data with administrative data to obtain information about health service use. Some participants will be invited for in-depth face-to-face interviews. The cohort study will be supplemented by linked research focusing on: the co-production of new measures of living well; including the perspectives of people with advanced dementia living in residential care settings; including people with dementia from black, Asian, and minority ethnic groups; and understanding the experience of people living with undiagnosed dementia. DISCUSSION IDEAL-2 will provide evidence about the key indicators of, and factors associated with, living well over the course of dementia and how these differ for particular subgroups. It will tell us which combinations of services and support are most beneficial and cost-effective. Moreover, the IDEAL-2 study will gather evidence from under-researched groups of people with dementia, who are likely to have their own distinct perceptions of living well.
Collapse
Affiliation(s)
- Barbora Silarova
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Sharon M. Nelis
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Rosalie M. Ashworth
- Alzheimer’s Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Clive Ballard
- College of Medicine and Health, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Marta Bieńkiewicz
- Alzheimer’s Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Catherine Henderson
- London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK
| | | | - John V. Hindle
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Julian C. Hughes
- RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, BA1 3NG UK
- University of Bristol, Department of Population and Health Sciences, Bristol Medical School, Bristol, BS8 2BN UK
| | - Ruth A. Lamont
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | | | - Ian R. Jones
- WISERD, Cardiff University, 38 Park Place, Cardiff, CF10 3BB UK
| | - Roy W. Jones
- RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, BA1 3NG UK
| | - Martin Knapp
- London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK
| | - Piers Kotting
- College of Medicine and Health, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Anthony Martyr
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Fiona E. Matthews
- Newcastle University, Institute for Health and Society, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL UK
| | - Robin G. Morris
- King’s College London, Henry Wellcome Building, Institute of Psychiatry, Psychology, and Neuroscience, De Crespigny Park, London, SE5 8AF UK
| | - Catherine Quinn
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Jemma Regan
- Alzheimer’s Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Jennifer M. Rusted
- University of Sussex, School of Psychology, Pevensey 1 2B21, Falmer, Brighton, BN1 9QH UK
| | - Eleanor Ann van den Heuvel
- Brunel University London, College of Health and Life Sciences, Department of Clinical Sciences, Kingston Lane, Uxbridge, UB8 3PH UK
| | - Christina R. Victor
- Brunel University London, College of Health and Life Sciences, Department of Clinical Sciences, Kingston Lane, Uxbridge, UB8 3PH UK
| | - Yu-Tzu Wu
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| | - Linda Clare
- Alzheimer’s Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke’s Campus, Exeter, EX1 2LU UK
| |
Collapse
|
3
|
Silarova B, Nelis SM, Ashworth RM, Ballard C, Bieńkiewicz M, Henderson C, Hillman A, Hindle JV, Hughes JC, Lamont RA, Litherland R, Jones IR, Jones RW, Knapp M, Kotting P, Martyr A, Matthews FE, Morris RG, Quinn C, Regan J, Rusted JM, van den Heuvel EA, Victor CR, Wu YT, Clare L. Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life. BMC Public Health 2018. [PMID: 30376832 DOI: 10.1186/s12889‐018‐6129‐7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND There is a major need for longitudinal research examining the experiences of people with dementia and their primary carers, as relatively little is known about how the factors associated with capability to 'live well' vary over time. The main aim of the IDEAL-2 study is to investigate how and why, over time, people with dementia and their primary carers might vary in their capability to live well with dementia, whilst exploring both their use of health and care services and their unmet needs. METHODS IDEAL-2 will build on the Improving the experience of Dementia and Enhancing Active Life (IDEAL) cohort of 1547 people (who, at recruitment between July 2014 and July 2016, had mild-to-moderate dementia), and their 1283 primary carers in Great Britain. The existing cohort will be enriched with additional participants with mild-to-moderate dementia (and their primary carers where available and willing) from the following groups: people with rarer forms of dementia, and/or those who are ≥90 years or < 65 years of age at time of recruitment. We will assess the primary outcome, capability to live well with dementia, and the factors influencing it using questionnaires at yearly intervals for 3 years. Additionally, we will seek to link the cohort data with administrative data to obtain information about health service use. Some participants will be invited for in-depth face-to-face interviews. The cohort study will be supplemented by linked research focusing on: the co-production of new measures of living well; including the perspectives of people with advanced dementia living in residential care settings; including people with dementia from black, Asian, and minority ethnic groups; and understanding the experience of people living with undiagnosed dementia. DISCUSSION IDEAL-2 will provide evidence about the key indicators of, and factors associated with, living well over the course of dementia and how these differ for particular subgroups. It will tell us which combinations of services and support are most beneficial and cost-effective. Moreover, the IDEAL-2 study will gather evidence from under-researched groups of people with dementia, who are likely to have their own distinct perceptions of living well.
Collapse
Affiliation(s)
- Barbora Silarova
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK.
| | - Sharon M Nelis
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Rosalie M Ashworth
- Alzheimer's Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Clive Ballard
- College of Medicine and Health, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Marta Bieńkiewicz
- Alzheimer's Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Catherine Henderson
- London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK
| | | | - John V Hindle
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Julian C Hughes
- RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, BA1 3NG, UK.,University of Bristol, Department of Population and Health Sciences, Bristol Medical School, Bristol, BS8 2BN, UK
| | - Ruth A Lamont
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | | | - Ian R Jones
- WISERD, Cardiff University, 38 Park Place, Cardiff, CF10 3BB, UK
| | - Roy W Jones
- RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, BA1 3NG, UK
| | - Martin Knapp
- London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK
| | - Piers Kotting
- College of Medicine and Health, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Anthony Martyr
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Fiona E Matthews
- Newcastle University, Institute for Health and Society, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK
| | - Robin G Morris
- King's College London, Henry Wellcome Building, Institute of Psychiatry, Psychology, and Neuroscience, De Crespigny Park, London, SE5 8AF, UK
| | - Catherine Quinn
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Jemma Regan
- Alzheimer's Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Jennifer M Rusted
- University of Sussex, School of Psychology, Pevensey 1 2B21, Falmer, Brighton, BN1 9QH, UK
| | - Eleanor Ann van den Heuvel
- Brunel University London, College of Health and Life Sciences, Department of Clinical Sciences, Kingston Lane, Uxbridge, UB8 3PH, UK
| | - Christina R Victor
- Brunel University London, College of Health and Life Sciences, Department of Clinical Sciences, Kingston Lane, Uxbridge, UB8 3PH, UK
| | - Yu-Tzu Wu
- Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| | - Linda Clare
- Alzheimer's Society Centre of Excellence, Centre for Research in Ageing and Cognitive Health (REACH), College of Medicine and Health, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK
| |
Collapse
|
4
|
Kotting P, Beicher K, McKeith IG, Rossor MN. Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network. Alzheimers Res Ther 2012; 4:23. [PMID: 22769969 PMCID: PMC3506937 DOI: 10.1186/alzrt126] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Clinical research is best done when aligned with clinical care - that is, when the patient can be identified, recruited and, in many instances, researched in parallel with the delivery of clinical service. However, to achieve this effectively requires identification of the additional cost to the National Health Service clinical support services and the development of an appropriately skilled workforce. The National Institute for Health Research (NIHR) Cancer Research Network demonstrated the value of dedicated research support in terms of the number of patients recruited into clinical trials. Building on this model, the NIHR in England funded the Dementias and Neurodegenerative Diseases Research Network (DeNDRoN). DeNDRoN is now in its sixth year and has established a geographically widespread network of research support staff and research leadership managed by a central coordinating centre. Success can already be measured by a significant increase in the number of patients entering studies and the speed with which both commercial and noncommercial studies are completed. There are also early indications that the network will result in improved patient outcomes.
Collapse
Affiliation(s)
- Piers Kotting
- Department of Neurodegenerative Diseases, Institute of Neurology, University College London, London WC1N 3BG, UK
| | - Kris Beicher
- Newcastle University, Wolfson Research Center, Institute of Ageing & Health, Newcastle Upon Tyne NE4 5PL, UK
| | - Ian G McKeith
- Newcastle University, Wolfson Research Center, Institute of Ageing & Health, Newcastle Upon Tyne NE4 5PL, UK
| | - Martin N Rossor
- Department of Neurodegenerative Diseases, Institute of Neurology, University College London, London WC1N 3BG, UK
| |
Collapse
|
5
|
Darbyshire J, Sitzia J, Cameron D, Ford G, Littlewood S, Kaplan R, Johnston D, Matthews D, Holloway J, Chaturvedi N, Morgan C, Riley A, Rossor M, Kotting P, McKeith I, Smye S, Gower J, Brown V, Smyth R, Poustie V, van't Hoff W, Wallace P, Ellis T, Wykes T, Burns S, Rosenberg W, Lester N, Stead M, Potts V, Johns C, Campbell H, Hamilton R, Sheffield J, Selby P. Extending the clinical research network approach to all of healthcare. Ann Oncol 2012; 22 Suppl 7:vii36-vii43. [PMID: 22039143 DOI: 10.1093/annonc/mdr424] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The development of Clinical Research Networks (CRN) has been central to the work conducted by Health Departments and research funders to promote and support clinical research within the NHS in the UK. In England, the National Institute for Health Research has supported the delivery of clinical research within the NHS primarily through CRN. CRN provide the essential infrastructure within the NHS for the set up and delivery of clinical research within a high-quality peer-reviewed portfolio of studies. The success of the National Cancer Research Network is summarized in Chapter 5. In this chapter progress in five other topics, and more recently in primary care and comprehensively across the NHS, is summarized. In each of the 'topic-specific' networks (Dementias and Neurodegenerative Diseases, Diabetes, Medicines for Children, Mental Health, Stroke) there has been a rapid and substantial increase in portfolios and in the recruitment of patients into studies in these portfolios. The processes and the key success factors are described. The CRN have worked to support research supported by pharmaceutical, biotechnology and medical device companies and there has been substantial progress in improving the speed, cost and delivery of these 'industry' studies. In particular, work to support the increased speed of set up and delivery of industry studies, and to embed this firmly in the NHS, was explored in the North West of England in an Exemplar Programme which showed substantial reductions in study set-up times and improved recruitment into studies and showed how healthcare (NHS) organizations can overcome delays in set up times when they actively manage the process. Seven out of 20 international studies reported that the first patient to be entered anywhere in the world was from the UK. In addition, the CRN have supported research management and governance, workforce development and clinical trials unit collaboration and coordination. International peer reviews of all of the CRN have been positive and resulted in the continuation of the system for a further 5 years in all cases.
Collapse
|